Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EPOCH BIOSCIENCES INC | 686,438 | reported | 21 Apr 2004 | tx 2+148,197−10,000 |
| CORAUTUS GENETICS INC | 85,760 | reported | 15 Nov 2010 | tx 6+12,652,011 |
| NEORX CORP | 36,144 | reported | 09 Jun 2011 | tx 161+2,631,823−553,618 |
| MEDAREX INC | 18,000 | reported | 11 Aug 2004 | tx 6+352,807 |
| INCYTE CORP | 10,000 | reported | 25 May 2004 | tx 3+76,793 |
| Twist Bioscience Corp | 5,590 | reported | 23 Jul 2019 | tx 7+72,361−66,771 |
| Dermira, Inc. | 0 | reported | 20 Feb 2020 | tx 34+3,573,095−7,010,620 |
| MADRIGAL PHARMACEUTICALS, INC. | 0 | reported | 13 Mar 2025 | tx 79+6,100,764−6,052,789 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 75 | 330.23 USD | |
| 13 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 967 | 329.86 USD | |
| 13 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 400 | 328.68 USD | |
| 13 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 1,000 | 327.63 USD | |
| 13 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 800 | 325.63 USD | |
| 13 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 900 | 324.69 USD | |
| 13 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 1,649 | 323.47 USD | |
| 13 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 1,951 | 322.45 USD | |
| 13 Mar 2025 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 7,742 | 65.06 USD | |
| 12 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 200 | 334.97 USD | |
| 12 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 800 | 333.66 USD | |
| 12 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 2,382 | 332.38 USD | |
| 12 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 2,759 | 331.36 USD | |
| 12 Mar 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 1,587 | 330.54 USD | |
| 12 Mar 2025 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 6,000 | 111.06 USD | |
| 12 Mar 2025 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 1,728 | 65.06 USD | |
| 12 Mar 2025 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 1,728 | 0.00 USD | deriv |
| 12 Mar 2025 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 6,000 | 0.00 USD | deriv |
| 13 Mar 2025 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 7,742 | 0.00 USD | deriv |
| 03 Dec 2024 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 520 | 315.90 USD | |
| 03 Dec 2024 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 3,080 | 315.21 USD | |
| 25 Nov 2024 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 1,200 | 350.71 USD | |
| 25 Nov 2024 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 2,200 | 350.08 USD | |
| 13 Sept 2024 | GIFT | MADRIGAL PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | |
| 25 Jun 2024 | GRANT_AWARD | MADRIGAL PHARMACEUTICALS, INC. | 714 | 0.00 USD |
4 purchases reported after at least 12 months of silence — most recent on 19 Nov 2018.